Eugenia Ulzurrun

987 total citations
21 papers, 674 citations indexed

About

Eugenia Ulzurrun is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Eugenia Ulzurrun has authored 21 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Eugenia Ulzurrun's work include Drug-Induced Hepatotoxicity and Protection (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Eugenia Ulzurrun is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (9 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Eugenia Ulzurrun collaborates with scholars based in Spain, United States and Chile. Eugenia Ulzurrun's co-authors include M. Isabel Lucena, Raúl J. Andrade, Manuel Romero‐Gómez, Mercedes Robles‐Díaz, Camilla Stephens, M. Carmen Fernández, Y. Borraz, José A. G. Agúndez, Elena Garcı́a-Martı́n and Ramón Planas and has published in prestigious journals such as Bioinformatics, Gastroenterology and PLoS ONE.

In The Last Decade

Eugenia Ulzurrun

17 papers receiving 657 citations

Peers

Countries citing papers authored by Eugenia Ulzurrun

Since Specialization

Citations

This map shows the geographic impact of Eugenia Ulzurrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia Ulzurrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia Ulzurrun more than expected).

Fields of papers citing papers by Eugenia Ulzurrun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia Ulzurrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia Ulzurrun. The network helps show where Eugenia Ulzurrun may publish in the future.

Co-authorship network of co-authors of Eugenia Ulzurrun

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia Ulzurrun. A scholar is included among the top collaborators of Eugenia Ulzurrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia Ulzurrun. Eugenia Ulzurrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	FDA Drug Repurposing Uncovers Modulators of Dopamine D ₂ Receptor Localization via Disruption of the NCS-1 Interaction	Journal of Medicinal Chemistry	Eugenia Ulzurrun, Eulalia Rodrı́guez-Martı́n et al.	0
2	AI-Driven De Novo Design and Development of Nontoxic DYRK1A Inhibitors	Journal of Medicinal Chemistry	Eugenia Ulzurrun, Concepción Pérez et al.	1
3	Scipion flexibility hub and Scipion chem: New frameworks coupling computational biophysics of protein dynamics and virtual screening to cryo-electron microscopy	Biophysical Journal	James Krieger, Marcos Gragera et al.	0
4	Scipion-Chem: An Open Platform for Virtual Drug Screening	Journal of Chemical Information and Modeling	Eugenia Ulzurrun, Nuria E. Campillo et al.	1
5	Benzodioxane–Benzamides as FtsZ Inhibitors: Effects of Linker’s Functionalization on Gram-Positive Antimicrobial Activity	Antibiotics	William Margolin, Eugenia Ulzurrun et al.	3
6	Multitarget drugs as potential therapeutic agents for alzheimer’s disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors	Journal of Enzyme Inhibition and Medicinal Chemistry	Concepción Pérez, Adrián Gironda-Martínez et al.	7
7	PLIDflow: an open-source workflow for the online analysis of protein–ligand docking using galaxy	Bioinformatics	Eugenia Ulzurrun, Yorley Duarte et al.	2
8	Computational workflow for the fine-grained analysis of metagenomic samples	BMC Genomics	Jose A. Arjona-Medina, Eugenia Ulzurrun et al.	4
9	Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury	Gastroenterology	Mercedes Robles‐Díaz, M. Isabel Lucena et al.	223
10	Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort	PLoS ONE	Eugenia Ulzurrun, Camilla Stephens et al.	14
11	HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity	PLoS ONE	Camilla Stephens, Miguel Ángel López‐Nevot et al.	71
12	Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug‐induced liver injury	Liver International	Eugenia Ulzurrun, Camilla Stephens et al.	34
13	Hepatotoxicidad, un problema global con especificidades locales: hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad	Gastroenterología y Hepatología	M. Isabel Lucena, Henry Cohen et al.	8
14	Mitochondrial Superoxide Dismutase and Glutathione Peroxidase in Idiosyncratic Drug-Induced Liver Injury	Hepatology	M. Isabel Lucena, Elena Garcı́a-Martı́n et al.	75
15	Drug-Induced Liver Injury: Insights from Genetic Studies	Pharmacogenomics	Raúl J. Andrade, Mercedes Robles‐Díaz et al.	70
16	Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to drug-induced liver injury # † ‡	Hepatology	M. Isabel Lucena, Carmen Martı́nez et al.	0
17	Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients	Journal of Diabetes and its Complications	Pedro Valdivielso, María José Ariza et al.	15
18	Glutathione S‐transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug‐induced liver injury†	Hepatology	M. Isabel Lucena, Raúl J. Andrade et al.	138
19	5-HT1A receptor activation counteracted the effect of acute immobilization of noradrenergic neurons in the rat locus coeruleus	Neuroscience Letters	José Rioja, Luis J. Santín et al.	6
20	We-P11:5 Postprandial lipemia and insulin resistance in individuals with and without type 2 diabetes	Atherosclerosis Supplements	José Rioja, María José Ariza et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact